Coleman, Brian C.
Purcell, Natalie
Geda, Mary
Luther, Stephen L.
Peduzzi, Peter
Kerns, Robert D.
Seal, Karen H.
Burgess, Diana J.
Rosen, Marc I.
Sellinger, John
Salsbury, Stacie A.
Gelman, Hannah
Brandt, Cynthia A.
Edwards, Robert R.
Funding for this research was provided by:
National Center for Complementary and Integrative Health (U24-AT009769)
National Center for Complementary and Integrative Health (UG3/UH3-AT009758)
National Center for Complementary and Integrative Health (UG3/UH3-AT009761)
National Center for Complementary and Integrative Health (UG3/UH3-AT009765)
U.S. Department of Defense
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-18-2-0003)
Office of Behavioral and Social Sciences Research
U.S. Army Medical Research Acquisition Activity
Health Services Research and Development (SDR-17-306)
Office of Research on Women's Health
This article is maintained by: Elsevier
Article Title: Assessing the impact of the COVID-19 pandemic on pragmatic clinical trial participants
Journal Title: Contemporary Clinical Trials
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cct.2021.106619
Content Type: article
Copyright: Published by Elsevier Inc.